CPIX
Price:
$2.51
Market Cap:
$35.25M
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibat...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-08-11
Stock Exchange
NASDAQ
Ticker
CPIX
According to Cumberland Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.30. This represents a change of 12.11% compared to the average of -2.94 of the last 4 quarters.
The mean historical PE Ratio of Cumberland Pharmaceuticals Inc. over the last ten years is 0.62. The current -3.30 PE Ratio has changed -53398.11% with respect to the historical average. Over the past ten years (40 quarters), CPIX's PE Ratio was at its highest in in the March 2015 quarter at 612.05. The PE Ratio was at its lowest in in the June 2016 quarter at -380.44.
Average
0.62
Median
-7.68
Minimum
-91.67
Maximum
120.22
Discovering the peaks and valleys of Cumberland Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 176.58%
Maximum Annual PE Ratio = 120.22
Minimum Annual Increase = -197.65%
Minimum Annual PE Ratio = -91.67
Year | PE Ratio | Change |
---|---|---|
2023 | -4.08 | -29.72% |
2022 | -5.80 | -53.36% |
2021 | -12.44 | 84.22% |
2020 | -6.75 | -21.57% |
2019 | -8.61 | -36.17% |
2018 | -13.49 | -8.12% |
2017 | -14.68 | -83.99% |
2016 | -91.67 | -176.25% |
2015 | 120.22 | 176.58% |
2014 | 43.47 | -197.65% |
The current PE Ratio of Cumberland Pharmaceuticals Inc. (CPIX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-7.44
5-year avg
-7.53
10-year avg
0.62
Cumberland Pharmaceuticals Inc.’s PE Ratio is less than Eagle Pharmaceuticals, Inc. (0.19), greater than Regencell Bioscience Holdings Limited (-13.79), less than Procaps Group S.A. (7.23), less than Incannex Healthcare Limited (-2.55), less than Petros Pharmaceuticals, Inc. (-0.27), less than Evoke Pharma, Inc. (-1.12), less than Agile Therapeutics, Inc. (-0.65), less than PainReform Ltd. (-0.87), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.20), less than Mallinckrodt plc (-0.04), greater than Organogenesis Holdings Inc. (-57.13), less than Lucy Scientific Discovery Inc. (-1.23), greater than Alimera Sciences, Inc. (-20.50), less than Lifecore Biomedical, Inc. (35.87), less than Kamada Ltd. (21.25), less than Ironwood Pharmaceuticals, Inc. (29.47), less than Biofrontera Inc. (-0.45), less than Guardion Health Sciences, Inc. (0.65), less than Akanda Corp. (-0.04), less than China Pharma Holdings, Inc. (-0.67),
Company | PE Ratio | Market cap |
---|---|---|
0.19 | $6.74M | |
-13.79 | $67.32M | |
7.23 | $279.80M | |
-2.55 | $30.87M | |
-0.27 | $2.89M | |
-1.12 | $7.28M | |
-0.65 | $10.43M | |
-0.87 | $2.62M | |
-0.20 | $2.83M | |
-0.04 | $4.52M | |
-57.13 | $399.81M | |
-1.23 | $906.91K | |
-20.50 | $301.29M | |
35.87 | $279.89M | |
21.25 | $347.79M | |
29.47 | $737.73M | |
-0.45 | $7.83M | |
0.65 | $4.35M | |
-0.04 | $2.20M | |
-0.67 | $3.56M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cumberland Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cumberland Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cumberland Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Cumberland Pharmaceuticals Inc. (CPIX)?
What is the highest PE Ratio for Cumberland Pharmaceuticals Inc. (CPIX)?
What is the 3-year average PE Ratio for Cumberland Pharmaceuticals Inc. (CPIX)?
What is the 5-year average PE Ratio for Cumberland Pharmaceuticals Inc. (CPIX)?
How does the current PE Ratio for Cumberland Pharmaceuticals Inc. (CPIX) compare to its historical average?